0.840
0.84 (0%)
As of Dec 20, 2024
Gossamer Bio, Inc. [GOSS]
Source:
Company Overview
Gossamer Bio, Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension, or PAH.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | (858) 684-1300 |
| Industry | manufacturing |
| CEO | Faheem Hasnain |
| Website | www.gossamerbio.com |